These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2644365

  • 1. Treatment of children symptomatic with human immunodeficiency virus infection.
    Wilfert CM, McKinney R.
    J Infect; 1989 Jan; 18 Suppl 1():81-2. PubMed ID: 2644365
    [No Abstract] [Full Text] [Related]

  • 2. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.
    McKinney RE, Pizzo PA, Scott GB, Parks WP, Maha MA, Lehrman SN, Riggs M, Eddy J, Lane BA, Eppes SC.
    J Pediatr; 1990 Apr; 116(4):640-7. PubMed ID: 2181102
    [Abstract] [Full Text] [Related]

  • 3. Clinical trials of zidovudine in HIV infection.
    Lancet; 1989 Aug 26; 2(8661):483-4. PubMed ID: 2570190
    [No Abstract] [Full Text] [Related]

  • 4. Preliminary report of a multicentre study of zidovudine plus or minus acyclovir in patients with acquired immune deficiency syndrome or acquired immune deficiency syndrome-related complex.
    Fiddian AP.
    J Infect; 1989 Jan 26; 18 Suppl 1():79-80. PubMed ID: 2644364
    [No Abstract] [Full Text] [Related]

  • 5. [Decrease in human immunodeficiency virus antigen levels in the cerebrospinal fluid during zidovudine treatment in patients with AIDS].
    de Gans J, Lange JM, Derix MM, de Wolf F, Ongerboer de Visser BW, Goudsmit J.
    Ned Tijdschr Geneeskd; 1988 Sep 03; 132(36):1656-60. PubMed ID: 3050555
    [No Abstract] [Full Text] [Related]

  • 6. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA, Gelber RD, McGrath N, Wara D, Barzilai A, Abrams E, Bryson YJ, Dankner WM, Livingston RA, Connor EM.
    N Engl J Med; 1994 Nov 03; 331(18):1181-7. PubMed ID: 7935655
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE, Leuther MD, Allain JP, Nusinoff-Lehrman S, Boone GS, Feigal D, Volberding P.
    Arch Intern Med; 1988 Oct 03; 148(10):2151-3. PubMed ID: 3263098
    [Abstract] [Full Text] [Related]

  • 9. [Treatment of HIV infection with zidovudine. The good use of AZT].
    Régnier B.
    Rev Prat; 1991 Sep 01; 41(19):1801-4. PubMed ID: 1925359
    [No Abstract] [Full Text] [Related]

  • 10. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long-term experience.
    Smiley L.
    J Infect; 1989 Jan 01; 18 Suppl 1():77. PubMed ID: 2644363
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. AZT for children with AIDS.
    Engel NS.
    MCN Am J Matern Child Nurs; 1989 Jan 01; 14(2):121. PubMed ID: 2495409
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Early HIV infection: to treat or not to treat?
    Swart AM, Weller I, Darbyshire JH.
    BMJ; 1990 Oct 13; 301(6756):825-6. PubMed ID: 2282416
    [No Abstract] [Full Text] [Related]

  • 15. Zidovudine--the first year of experience.
    Williams I, Gabriel G, Cohen H, Williams P, Tedder RS, Machin S, Weller IV.
    J Infect; 1989 Jan 13; 18 Suppl 1():23-31. PubMed ID: 2915140
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Probenecid and zidovudine metabolism.
    Kornhauser DM, Petty BG, Hendrix CW, Woods AS, Nerhood LJ, Bartlett JG, Lietman PS.
    Lancet; 1989 Aug 26; 2(8661):473-5. PubMed ID: 2570186
    [Abstract] [Full Text] [Related]

  • 20. The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker.
    Spector SA, Kennedy C, McCutchan JA, Bozzette SA, Straube RG, Connor JD, Richman DD.
    J Infect Dis; 1989 May 26; 159(5):822-8. PubMed ID: 2496173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.